Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1491741

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1491741

Polymerase Chain Reaction Market Size, Share, Growth Analysis, By Type, By Product, By Application, By By Indication - Industry Forecast 2024-2031

PUBLISHED:
PAGES: 219 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Polymerase Chain Reaction (PCR) Market size was valued at USD 24.17 billion in 2022 and is poised to grow from USD 24.75 billion in 2023 to USD 29.92 billion by 2031, growing at a CAGR of 2.4% during the forecast period (2024-2031).

In recent years, the global polymerase chain reaction (PCR) market has experienced remarkable growth and remains a crucial technology in molecular biology and diagnostics. PCR, a versatile method for amplifying and analyzing DNA and RNA samples, plays a fundamental role across various fields including research, clinical diagnostics, forensic analysis, and biotechnology. Driving this growth are factors such as the rising incidence of infectious diseases, the demand for personalized medicines, advancements in genomics research, and the urgent need for rapid and accurate diagnostic tools, especially in response to the COVID-19 pandemic. The market is characterized by numerous prominent players offering a wide array of PCR instruments, consumables, and services. Traditional PCR techniques are evolving towards more efficient and automated systems like real-time PCR and digital PCR, offering quicker results and enhanced sensitivity. Furthermore, the development of portable PCR devices has expanded the market's reach into point-of-care settings.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Polymerase Chain Reaction (PCR) Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Polymerase Chain Reaction (PCR) Market Segmental Analysis

The polymerase chain reaction (PCR) market is segmented based on type, product, indication, end user, and region. By type, the market is segmented into standard PCR, real-time PCR, digital PCR, and others. By product, the market is segmented into instruments, reagents & consumables, and software & services. By indication, the market is segmented into infectious diseases, oncology, genetic disorders, and others. By application, the market is segmented into medical and non-medical. Medical applications are further sub-segmented into clinical (pathology testing, oncology testing, blood screening, and others), research, forensics, and others. Non-medical applications are further sub-segmented into food, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Polymerase Chain Reaction (PCR) Market

PCR is widely employed in molecular diagnostics to detect and monitor various diseases, including infectious diseases, cancer, and genetic disorders. The increasing demand for accurate and swift diagnostic tools, especially amidst the COVID-19 pandemic, has bolstered the need for PCR-based comprehensive tests and diagnostics, a trend expected to continue propelling the PCR market forward.

Restraints in the Global Polymerase Chain Reaction (PCR) Market

The high expenses associated with PCR units and consumables pose a significant obstacle for smaller laboratories, clinics, and research facilities. This financial barrier hampers accessibility to PCR technology in resource-limited settings, potentially impeding market expansion, especially in developing areas.

Market Trends of the Global Polymerase Chain Reaction (PCR) Market

A remarkable trend within the PCR marketplace was the increasing popularity of point-of-care (POC) PCR testing solutions, fueled by the necessity for swift and on-site diagnostic testing, notably amid the COVID-19 pandemic. POC PCR testing presents the advantage of rapid results, proving crucial in scenarios where timely diagnosis is imperative, such as infectious disease outbreaks. As healthcare providers and clinics pursued quicker and more convenient testing options, POC PCR devices and kits gained momentum in the market.

Product Code: SQMIG35H2241

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Technology Analysis
  • Value Chain Analysis
  • Pricing Analysis
  • Start Up Analysis
  • Regulatory Landscape
  • Patent Analysis
  • Pipeline Analysis
  • Key Success Factors
  • Market Attractiveness Index
  • Degree of Competition
  • Top Investment Pockets
  • Ecosystem Mapping

Polymerase Chain Reaction (PCR) Market by Type

  • Market Overview
  • Standard PCR
  • Real-time PCR
  • Digital PCR
  • Others

Polymerase Chain Reaction (PCR) Market by Product

  • Market Overview
  • Instruments
  • Reagents & Consumables
  • Software & Services

Polymerase Chain Reaction (PCR) Market by Indication

  • Market Overview
  • Infectious Diseases
  • Oncology
  • Genetic Disorders
  • Others

Polymerase Chain Reaction (PCR) Market by Application

  • Market Overview
  • Medical
    • Clinical
    • Pathology Testing
    • Oncology Testing
    • Blood Screening
    • Others
    • Research
    • Forensics
    • Others
  • Non-Medical
    • Food
    • Others

Polymerase Chain Reaction (PCR) Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Thermo Fisher Scientific, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Holdings AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • QIAGEN N.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • F. Hoffmann-La Roche Ltd. (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Promega Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fluidigm Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eppendorf AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takara Bio Inc. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioMerieux SA (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerkinElmer, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioFire Diagnostics, LLC (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biosearch Technologies, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GenMark Diagnostics, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Enzo Biochem, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Illumina, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • New England Biolabs, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Quantabio (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LGC Limited (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bioer Technology Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!